OM1, a healthcare data and analytics company, raised $85 million in a Series D financing round co-led by Oakland, California-based Kaiser Permanente. D1 Capital Partners and Breyer Capital joined ...

BOSTON--(BUSINESS WIRE)--OM1, a leading real-world data, outcomes, and technology company with a focus on chronic conditions, today announced the launch of two new Real-World Analytics products – ...

The depth of data derived from the new dataset will contribute to early disease intervention and research to improve patient outcomes and quality of life BOSTON, July 30, 2024--(BUSINESS WIRE)--OM1, ...

BOSTON--(BUSINESS WIRE)--OM1, the leader in real-world evidence generation and insights for life sciences, proudly announces the appointment of Catherine Richards, PhD, MPH, as its first President.

OM1, a leader in real-world evidence (RWE) generation and AI-driven insights for healthcare and life sciences, today announced that its Rheumatoid Arthritis (RA) specialty dataset achieved the highest ...

BOSTON, April 22, 2025--(BUSINESS WIRE)--OM1, the leader in real-world data and AI-driven insights for mental health, today announced a significant expansion of its specialty mental health network, ...

Lane to lead product and engineering strategy, driving innovation and growth in AI-powered real-world evidence and outcomes solutions for healthcare OM1, the leader in real-world evidence (RWE) ...

OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior ...

OM1, a big-data analytics company for the healthcare industry, has raised $50 million in its latest round of financing to expand its sales and marketing and product development activities as it brings ...